4.6 Meeting Abstract

A phase 1a/1b study of FPA008 in combination with nivolumab in patients with selected advanced cancers

Journal

CANCER IMMUNOLOGY RESEARCH
Volume 4, Issue 1, Pages -

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-B143

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available